Background: Pakistan's nutraceutical market is expanding rapidly amid weak regulatory oversight and limited consumer access to validated guidance. Self-medication, mega-dose supplement use, and misinformation are prevalent. Currently, no consumer-facing tool provides personalized, evidence-based nutrition support. Objective: To develop and pilot-test an AI chatbot delivering evidence-based nutritional and nutraceutical guidance within strict non-diagnostic boundaries. Methods: Data Curation: Information sourced from NIH ODS, Medscape, UpToDate, and peer-reviewed literature. Product Evaluation: Assessment of 1,000+ supplements from 30+ companies against GMP, ISO, and DRAP label-claimed certifications. Personalization Logic: Adaptive, context-aware recommendation framework. Safety Protocols: Cumulative toxicity prevention, consent-based nutraceutical guidance, and explicit non-diagnostic disclaimers. Key Features: Non-Diagnostic Scope: Clear boundary setting with referral to healthcare professionals when appropriate. Label-Verified Database: Products screened within NIH ODS safe intake ranges. On-Request Supplement Module: Nutraceutical recommendations provided only upon user request. Results: Internal pilot evaluation demonstrated high information clarity (85% positive), system helpfulness (70% positive), and cautious but constructive user reception to automated product guidance. No safety boundary violations were observed. Conclusion: AI-driven, evidence-based nutrition guidance is feasible in developing-country settings with limited regulatory oversight. This model offers scalable consumer education to reduce supplement misuse and address health literacy gaps.
Hassan et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: